The success of AAA establishment was validated by ultrasound analysis at termination, which demonstrated a profound expansion of suprarenal aortic diameter and area of abdominal aortas in mice administered Ang II (Figure 1A). The gene discussed is AGT; the disease is triple-A syndrome.